Circulating Levels of Urokinase-Type Plasminogen Activator Receptor and D-Dimer in Patients With Hematological Malignancies.

CONCLUSION: We found differences in D-D serum levels and soluble uPAR between control participants and patients with lymphoma. These results indicate that D-D serum levels and soluble uPAR should be considered biomarkers of response and survival in patients with lymphoma. PMID: 26423703 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26423703?dopt=Abstract

Source: Clinical Lymphoma and Myeloma - October 1, 2015 Category: Cancer & Oncology Authors: Rubio-Jurado B, Tello-González A, Bustamante-Chávez L, de la Peña A, Riebeling-Navarro C, Nava-Zavala AH Tags: Clin Lymphoma Myeloma Leuk Source Type: research